Vladimir Dergachev

Title: Innovations by Vladimir Dergachev

Introduction

Vladimir Dergachev is a notable inventor based in Netanya, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of Amphotericin B derivatives. With a total of 2 patents, his work focuses on enhancing the efficacy and safety of antifungal treatments.

Latest Patents

Dergachev's latest patents revolve around the derivatives of Amphotericin B. These embodiments provide derivatives that exhibit increased solubility and reduced toxicity compared to traditional Amphotericin B (AMB), while maintaining antifungal activity against various clinical fungal isolates. The derivatives include a polymer group with an amine group, linked to mycosamine via a stable amide linker. The general formula for these derivatives includes various configurations of R, which can be hydrogen, Calkyl, or phenyl, among others. This innovative approach aims to improve the therapeutic profile of Amphotericin B, making it a more viable option for treating fungal infections.

Career Highlights

Throughout his career, Dergachev has been associated with prestigious institutions such as Tel Aviv University and the Technion Research & Development Foundation Ltd. His work in these organizations has allowed him to collaborate with leading experts in the field, further enhancing his research and development efforts.

Collaborations

Dergachev has worked alongside notable colleagues, including Alex Martin Szpilman and Nir Osherov. These collaborations have contributed to the advancement of his research and the successful development of his patented innovations.

Conclusion

Vladimir Dergachev's contributions to the field of pharmaceuticals, particularly through his innovative Amphotericin B derivatives, highlight his role as a significant inventor. His work not only addresses critical challenges in antifungal treatments but also showcases the importance of collaboration in scientific research.